Searchable abstracts of presentations at key conferences in endocrinology

ea0073pep7.8 | Presented ePosters 7: Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Cholesterol-free ketogenic diet administration ameliorates experimental metabolic syndrome

Agosti Emanuela , Reano Simone , Provera Alessia , Gadipudi Laila Lavanya , Ramavath Naresh Naik , Colasanto Antonio , Raineri Davide , Albano Emanuele , Filigheddu Nicoletta , Arlorio Marco , Coisson Jean Daniel , Chiocchetti Annalisa , Sutti Salvatore , Prodam Flavia

Background and aimsMetabolic syndrome (MetS) is a pathologic condition characterized by abdominal obesity, insulin resistance, hypertension, and dyslipidemia. The prevalence of MetS parallels the rise of obesity rate reaching pandemic proportions due to the increased consumption of high-calories-high-fat-high-carbohydrates low-fibers diet associated with a sedentary lifestyle. MetS is associated with a plethora of comorbidities as non-alcoholic fatty liv...

ea0037ep1266 | Clinical Cases–Thyroid/Other | ECE2015

Hyponatraemic encephalopathy induced by single dose of indapamide

Haya Naik , Noordally Karim

Introduction: Hyponatraemia is the most common of electrolyte abnormalities. There are numerous factors which may directly cause or contribute to hyponatraemia, including dehydration, concomitant cardiac/hepatic/renal disease, and certain medications, such as diuretics. Hyponatraemia may cause a range of symptoms, depending on the speed and severity of the deficiency. Mild hyponatraemia (>115 mmol/l), can causes malaise, nausea and vomiting. Significant hyponatraemia, [Na<...

ea0025p41 | Clinical biochemistry | SFEBES2011

Tanned and pregnant-primary adrenal insufficiency during pregnancy

Haya Naik , Ajjan Ramzi

Primary adrenal failure is a rare condition with an incidence during pregnancy of around 1 case in 12 000 gestations.A 31 years old primi gravida presented 10 days after giving birth to a healthy child at full term with postural dizziness and severe fatigue. There was no history of excessive blood loss during delivery and her past medical history was unremarkable, but low blood pressure (BP) was reported throughout pregnancy. She mentioned increased body...

ea0077lb37 | Late Breaking | SFEBES2021

Thyroid dysfunction with Zoledronic acid infusion for osteoporosis

Kumar Sandeep , Brar KS , Bansal Naresh

Introduction: It has been seen that Zoledronic acid (ZA) infusion induces an acute inflammatory response associated with rise in inflammatory markers and changes in thyroid function tests resembling non thyroidal illness syndrome. It is also postulated that amino group of ZA has a role in causation of these thyroid function abnormality. (1)Material and methods: An observational study at tertiary care hospital of India where thyroid functions tests were s...

ea0075o13 | Obesity, metabolism &amp; miscellaneous endocrinology | EYES2021

Assessment of knowledge, attitudes and practices towards Endocrine Disrupting Chemicals (EDCs) among medical students of Punjab

Malhotra Kashish , Goyal Kashish , Malhotra Kashish , Goyal Naresh

Background: An endocrine disruptor is an exogenous chemical or mixture of chemicals that interfere with any aspect of hormone action. It can interfere with the body’s endocrine system and produce adverse cardiovascular, neurological, developmental, reproductive, and metabolic effects in humans. This study aims to evaluate the knowledge, attitude, and practices (KAP) of the medical students regarding the exposure, usage, and long-term harmful effects of Endocrine Disrupt...

ea0090p252 | Thyroid | ECE2023

Role of Ayurveda based novel ‘Thyroid detoxification program’ in the management of hypothyroid patients

Vikrant Patil Dr , Patil Dr. Sushama , Menkudale Bhavana , Naik Ninad

Background: The aim of study was to determine the effectiveness of Thyroid detoxification program therapy in patients of hypothyroidism, attending TATC clinic in Maharashtra. According to the clinical survey from various studies on thyroid disease, it has been estimated that about 32% of people suffer from thyroid diseases in India out of which 10.7 % of people have hypothyroidism. According to health experts, even though hypothyroidism is easy to detect and inexpensive to tre...

ea0063p362 | Thyroid 1 | ECE2019

Weekly dose of L-thyroxine as a first line treatment for hypothyroidism in young and middle aged working females

Wasoori Satish Chander , Naik Manoj Hari , Bhardwaj Chetan

Objective: To demonstrate the effectiveness and compliance to L-thyroxine in the treatment of hypothyroidism in a weekly dose of seven times of normal dose as an alternative to daily dosing in young and middle aged females.Methods: Randomized trial on 40 female patients aged between 25 to 55 years with long standing hypothyroidism of 5 years or more, currently on daily dose of L-thyroxine, were assigned weekly dose of seven ...

ea0049ep526 | Diabetes complications | ECE2017

Management of diabetic peripheral neuropathy (DPN) using low frequency pulsed electro magnetic field (LF-PEMF)

Wasoori Satish Chander , Pande Deepak G. , Bhardwaj Chetan , Naik Manoj

Objective: To evaluate the effectiveness of low frequency pulsed electro magnetic field (LF-PEMF) in the management of diabetic peripheral neuropathy (DPN) symptoms.Methods: A comparative observational study of 60 patients, male and female (1:1) aged 60–85 years. Enrolment criteria – known diabetics, HbA1c 7–9 and DPN of 1–5 years. Patients were randomized into 2 treatment groups G1 and G2. The study period was 4 weeks (w) with result...

ea0049ep526 (1) | Diabetes complications | ECE2017

Management of diabetic peripheral neuropathy (DPN) using low frequency pulsed electro magnetic field (LF-PEMF)

Wasoori Satish Chander , Pande Deepak G. , Bhardwaj Chetan , Naik Manoj

Objective: To evaluate the effectiveness of low frequency pulsed electro magnetic field (LF-PEMF) in the management of diabetic peripheral neuropathy (DPN) symptoms.Methods: A comparative observational study of 60 patients, male and female (1:1) aged 60–85 years. Enrolment criteria – known diabetics, HbA1c 7–9 and DPN of 1–5 years. Patients were randomized into 2 treatment groups G1 and G2. The study period was 4 weeks (w) with result...

ea0049ep1277 | Thyroid (non-cancer) | ECE2017

Hypothyroidism – once a week treatment option in young- and middle-aged adults

Chander Wasoori Satish , Naik Manoj , Pande Deepak G , Bhardwaj Chetan

Objective: To evaluate the effectiveness and compliance to L-thyroxine in the treatment of Hypothyroidism in a weekly dose of 7 times of normal dose as an alternative to daily dosing in young and middle aged adults.Methods: A randomized prospective observational study on 180 patients (female:male) ratio of 5:1 aged between 18 and 55 years with an established diagnosis of Hypothyroidism were assigned a weekly dose of seven times of normal dose. The patien...